Abstract
There is direct evidence that in galactosemia, due to galactose-1-phosphate uridyltransferase deficiency, galactose, galactose-1-phosphate and galactitol accumulate in the fetus by week 20 of gestation. The metabolic abnormality may develop earlier than this, however, since the key enzymes in galactose metabolism have been shown to be present in normal fetal liver from the 10th week of gestation. There has been a single report of increased galactitol in amniotic fluid obtained at 10 weeks gestation, the outcome being a baby affected with galactosemia. Cataract formation in the fetus is rare and the only direct evidence that galactosemia may have harmful effects in utero. However, it has been concluded that the liver pathology seen in some patients who died in the neonatal period originated prenatally, and some studies have found that galactosemia is associated with reduced birth weight. Reports of two patients with histologically normal ovaries very soon after birth have been cited as evidence against gonadal dysfunction arising during fetal life, but it should be noted that this is not a constant feature in female galactosemics. Other observations, particularly those made from animal models, would suggest that ovarian dysfunction is most likely to have been caused in utero.
Similar content being viewed by others
Abbreviations
- GALT :
-
Galactose-1-phosphate uridyltransferase
- Gal-1-P :
-
galactose-1-phosphate
- Glc-1-P :
-
glucose-1-phosphate
- UDPGal :
-
uridine diphosphate galactose
References
Abrahams HD, Howell RR (1969) Human hepatic uridine diphosphate pyrophosphorylase. J Biol Chem 244:545–550
Allen JT, Gillett M, Holton JB, King GS, Pettit BR (1980) Evidence of galactosaemia in utero. Lancet II:603
Belman AL, Moshe SL, Zimmerman RD (1986) Computed tomographic demonstration of cerebral edema in a child with galactosemia. Pediatrics 78:606–609
Brivet M, Raymond JP, Konopka P, Odievre M, Lemmonier A (1989) Effect of lactation in a mother with galactosemia. J Pediatr 115:280–282
Donnell GN, Koch R, Bergren WR (1969) Observations on results of management of galactosemic patients. In: Hsia DY-Y (ed) Galactosemia. CC Thomas, Springfield Illinois, pp 247–268
Donnell GN, Koch R, Fishler C, Ng WG (1980) Clinical aspects of galactosaemia. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP Press, Lanchester, pp 103–115
Gitzelman R (1969) Formation of galactose-1-phosphate from uridine diphosphate galactose in erythrocytes of patients with galactosemia. Pediatr Res 3:279–286
Gitzelmann R (1995) Galactose-1-phosphate in the pathophysiology of galactosemia. Eur J Pediatr 154 [Suppl 2]:S45-S49
Gitzelmann R, Steinmann B (1973) Uridine diphosphate galactose-4-epimerase deficiency. Helv Paediatr Acta 28:497–510
Hsia DY-Y, Walker FA (1961) Variability in the clinical manifestations of galactosemia. J Pediatr 59:872–883
Irons M, Levy HL, Pueschel S, Castree K (1985) Accumulation of galactose-1-phosphate in the galactosemic fetus despite maternal milk avoidance. J Pediatr 107:261–263
Isselbacher KJ (1957) Evidence for an accessory pathway of galactose metabolism in mammalian liver. Science 126:652–653
Jakobs C, Kleijer WJ, Bakker HD, VanGennip AH, Przyrembel H, Niermeijer MF (1988) Dietary restriction of maternal lactose intake does not prevent accumulation of galactitol in fetuses affected with galactosaemia. Prenatal Diagn 8:641–645
Kaufman FR, McBride-Chang C, Manis FR, Wolff JA, Nelson MD (1995) Cognitive functioning, neurologic status and brain imaging in classical galactosemia. Eur J Pediatr 154 [Suppl 2]:S2-S5
Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R (1981) Hypergonadotrophic hypogonadism in female patients with galactosemia. N Engl J Med 304:994–998
Komrower GM (1973) Treatment of galactosaemia. In: Seakins JWT, Saunders RA, Toothill C (eds) Treatment of inborn errors of metabolism. Churchill Livingstone, New York, pp 113–123
Komrower GM (1982) Galactosaemiathirty years on, the experience of a generation. J Inherited Metab Dis 5:96–104
Leloir LF (1951) The enzymatic transformation of uridine diphosphate glucose into a galactose derivative. Arch Biochem Biophys 33:186–190
Levy HL, Porensky RS (1984) Ovarian failure in galactosemia. N Engl J Med 310:50
Ng WG, Donnell GN, Bergren WR, Alfi O, Golbus MS (1977) Prenatal diagnosis or galactosaemia. Clin Chim Acta 74:227–235
Quan-Ma R, Wells HJ, Wells WW (1966) Galactitol in the tissues of a galactosemic child. Am J Dis Child 112:477–478
Schwarz V (1960) The value of galactose phosphate determinations in the treatment of galactosaemia. Arch Dis Child 35:428–432
Shin YS, Rucker A von, Reith M, Endres W (1982) Assay of UDPGalactose-4-epimerase. Clin Chem 28:2332–2333
Shin YS, Niedermeier HP, Endres W, Schaub J, Weidinger S (1987) Agarose gel isoelectric focussing of UDPGalactose pyrophosphorylase and galactose-1-phosphate uridyl transferase. Developmental aspects of UDPGalactose pyrophosphorylase. Clin Chim Acta 166:27–35
Shin-Buehring YS, Beier T, Tan A, Osang M, Schaub J (1977) The activity of galactose-1-phosphate uridyl transferase and galactkinase in human fetal organs. Pediatr Res 11:1045–1051
Vannas A, Hogan MJ, Golbus MS, Wood I (1975) Lens changes in a galactosemic fetus. Am J Ophthalmol 80:726–733
Waggoner DD, Buist NRM, Donnell GN (1990) Long term prognosis in galactosaemia: results of a survey of 350 cases. J Inherited Metab Dis 13:802–818
Welch RJ, Milligan DWA (1987) Cerebral oedema and galactosemia. Pediatrics 80:597–598
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holton, J.B. Effects of galactosemia in utero. Eur J Pediatr 154 (Suppl 2), S77–S81 (1995). https://doi.org/10.1007/BF02143809
Issue Date:
DOI: https://doi.org/10.1007/BF02143809